Barcelona snapshots

Prof. Michael E. Thase

Michael E. Thase  psychiatrist Controversias Psiquiatry Barcelona
University of Pennsylvania, USA
Talk Psychiatric and medical comorbidity as contributing factors in treatment-resistant depression
Date Saturday, April 27th, 2019
Time 11:45 to 12:30


Michael E. Thase is Professor of Psychiatry at the Perelman School of Medicine of the University of Pennsylvania, where he is Director of the Mood and Anxiety Disorders Section and a member of the medical staff of the Philadelphia Veterans Affairs Medical Center. Before joining the Penn faculty in January, 2007, Dr. Thase was a member of the faculty for more than 23 years at the University of Pittsburgh Medical Center. Dr. Thase’s research focuses on the assessment and treatment of mood disorders, including studies of the differential therapeutics of both depression and bipolar affective disorder. He has conducted seminal studies on novel antidepressants, cognitive behavior therapy, and treatment resistant depression and was one of the architects of both the STAR*D and STEP-BD studies. Current research projects are examining novel ketamine-like drugs, the predictive value of pharmacogenomics for antidepressant therapy and ways to improve and sustain the outcomes of neuromodulation strategies with CBT. A 1979 graduate of the Ohio State University College of Medicine, Dr. Thase is a Distinguished Life Fellow of the American Psychiatric Association, a Founding Fellow of the Academy of Cognitive Therapy, and President of the American Society of Clinical Psychopharmacology. He also has been elected to the membership of the American College of Psychiatrists and is a Fellow of the American College of Neuropsychopharmacology. Dr. Thase has authored or co-authored over 900 scientific articles and book chapters, as well as 17 books.